CSL312_3003
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CSL312_3003, covering 2026-01-26 to 2026-06-02. Get the full timeline:
Most recent: Clinical Trial Update: CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema [Phase 3]